We previously verified that polymorphisms in EGR2 are associated with susceptibility to SLE [62], and that Egr2 is characteristically expressed in LAG3+ Tregs [63,64], which have the potential to ameliorate lupus pathology [59]. Here, LAG3 is linked to systemic lupus erythematosus.